Navigation Links
Biodel Reports Third Quarter Fiscal Year 2011 Financial Results
Date:8/4/2011

rrent assets29,56542,651Property and equipment, net2,9982,432Intellectual property, net5350Other assets—9Total assets$

32,616$

45,142LIABILITIES AND STOCKHOLDERS' EQUITYCurrent:Accounts payable$

1,989$

102Accrued expenses:Clinical trial expenses1,362974Payroll and related357954Accounting and legal fees300228Severance—686Other334241Income taxes payable4547Total current liabilities4,3873,232Common stock warrant liability4,1699,717Other long term liabilities—313Total liabilities$

8,556$

13,262CommitmentsStockholders' equity:Series A preferred stock, $.01 par value; 50,000,000 shares authorized; 0 and 1,813,944 outstanding—18Common stock, $.01 par value; 100,000,000 shares authorized; 26,399,764 and 38,605,483 issued and outstanding264386Additional paid-in capital188,549210,955Accumulated other comprehensive income1—Deficit accumulated during the development stage(164,754)(179,479)Total stockholders' equity24,06031,880Total liabilities and stockholders' equity$

32,616$

45,142Biodel Inc.
(A Development Stage Company)Condensed Statements of Operations(in thousands, except share and per share amounts)(unaudited)December 3,2003Three Months EndedNine Months Ended(inception) toJune 30,June 30,June 30,20102011201020112011Revenue$

—$

—$

—$

—$

—Operating expenses:Research and development5,8902,94121,65811,349127,577General and administrative2,7802,3828,5737,26454,889Total operating expenses8,6705,32330,23118,613182,466Other (income) and expense:Interest and other income(3)(20)(10)(30)(5,536)Interest expense————78Adjustment to fair value of common stock warrant liability —(1,355)—(3,890)(2,636)Loss on settlement of debt————627Operating loss before tax provision (benefit)(8,667)(3,948)(30,221)(14,693)(174,999)Tax provision (benefit)(38)26(35)32(580)Net loss(8
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study
2. Biodel to Raise $30 Million Through Registered Direct Offering
3. Biodel Inc. to Present at 29th Annual JPMorgan Healthcare Conference on January 13th, 2011
4. Biodel Announces Name Change for Lead Product Candidate
5. Dyadic International Reports 2011 Second Quarter Financial Results
6. Vermillion Reports Results for the Second Quarter 2011
7. ReportsnReports - Needle-Free Drug Delivery Market & Hospital-Acquired Infections (HAI) Diagnostics Market Reports
8. Dendreon Reports Second Quarter 2011 Financial Results
9. Cambrex Reports Second Quarter of 2011 Results
10. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
11. Gen-Probe Reports Financial Results for the Second Quarter of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... According to a new market research ... Forecasts (2015-2020), , published by Mordor Intelligence, the Global market ... end of 2020, with North America ... of the global market size. The Global market for Stem ... during the period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) ...
(Date:7/29/2015)... , July 29, 2015  AsureQuality and Ubiquitome ... testing for applications in food and primary production ... powered real-time PCR device, the Freedom4. ... through to the supermarket shelf for producers, processors ... involvement in animal disease control and pest management ...
(Date:7/29/2015)... , July 29, 2015  Therapath Neuropathology ... announces increased partnerships with VA and Military Medical ... Nerve Fiber Density (ENFD) and Sweat Gland Nerve ... fiber neuropathy ( https://therapath.com/skin ). ... Fiber Density (ENFD) on punch skin biopsy is ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... build Yondelis(R) sales network across Western Europe, ... a services agreement with PharmaMar, a subsidiary of ... oncology sales team in Western,Europe to promote Yondelis(R), ... the marketing authorization, will be,responsible for marketing the ...
... 3 Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ... discovery, development and commercialization of,novel small molecule ... Stolz, Ph.D., to the position of Vice ... be responsible for overseeing the,company,s partnering and ...
... the tiny structures look like fragments of nanoscopic pearl ... are linked together by means of a special fullerene-binding ... nanopearls in the latest issue of the journal Angewandte ... 60 carbon atoms whose linkages resemble the five- and ...
Cached Biology Technology:Innovex to Promote PharmaMar's Yondelis(R) Cancer Treatment 2Innovex to Promote PharmaMar's Yondelis(R) Cancer Treatment 3Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development 2Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development 3
(Date:7/8/2015)... -- The consumer products industry for innovative tech ... such as wearables, smart wallets & other smart technology are ... continues to rapidly grow.  Biometrics & Wearable Device Companies in ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ... GPRO ) and Baidu Inc. (NASDAQ: BIDU ) ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... but we know surprisingly little about how they form. ... has studied how extremely small cloud particles can dispose ... processes in the atmosphere that affect global climate change. ... climate change contain a major source of uncertainty, namely ...
... to prevent a patient going blind but there is ... is long. Scientists at the Sahlgrenska Academy at the University ... stem cells on human corneas, which may in the long ... corneal transplantations are carried out each year in Sweden, and ...
... to loud sounds, for example from portable music players. ... that my hearing is good, so I guess I ... from the University of Gothenburg, Sweden, shows that research-based ... adolescents, awareness and behaviour. Eva West, researcher at ...
Cached Biology News:New insights into cloud formation 2Stem cells can repair a damaged cornea 2Teaching about hearing can save young people's ears 2
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
... 1, active MW: 34.2kDa Formulation: 10mM ... Brij-35, 1mM dithiothreitiol with 50% glycerol ... to the Certificate of Analysis for ... salt precipitation followed by gel filtration ...
Supplemental reagent for annexin V assay....
Conjugate Quality Control Evaluation Specificity: Conjugate Quality Control Evaluation ...
Biology Products: